PSA and prostate cancer share many genetic loci17,19–22, but the extent to which this overlap reflects screening bias remains unclear, as GWASs of prostate cancer may capture signals for disease susceptibility and incidental detection due to benign PSA elevation. This evidence concerns the gene KLK3 and prostate carcinoma.